ELIOT KAMENITZ
/ The Times-Picayune
/ Associated Press
Water rushed over New Orleans' Industrial Canal floodwall yesterday in the wake of Hurricane Gustav, but officials said the city was spared major flooding. |
|
|
|
New Orleans sideswiped by weakened hurricane
Gustav downgraded to tropical storm
By Robert Tanner
and Vicki Smith
ASSOCIATED PRESS
NEW ORLEANS – A weaker-than-expected Hurricane Gustav swirled into the fishing villages and oil-and-gas towns of Louisiana's Cajun country yesterday, delivering a glancing blow to New Orleans that did little more than send water sloshing harmlessly over its rebuilt floodwalls. Late last night, the National Hurricane Center reclassified Gustav as a tropical storm as it crossed central Louisiana with winds of about 60 mph.
REPUBLICAN NATIONAL CONVENTION
Events roil opening of GOP convention
Gustav, pregnancy reshape proceedings
By Michael Abramowitz
and Dan Balz
THE WASHINGTON POST
ST. PAUL, Minn. – Republicans opened their scaled-down convention yesterday with calls for aid and compassion as Hurricane Gustav smashed into the Gulf Coast. But even before the gavel had come down to begin the proceedings, they were met with another distraction as the party's presumptive vice presidential nominee announced that her 17-year-old daughter is five months pregnant.
Scripps gets $80 million grant
Institute made hub of research network
By Terri Somers
STAFF WRITER
The Scripps Research Institute has been awarded more than $80 million – its largest grant ever – to be a research hub in a federally funded network that will ferret out new targets in the body that play a key role in disease.
Cholesterol drugs losing favor
Usefulness doubted for Zetia, Vytorin
By Alex Berenson
NEW YORK TIMES NEWS SERVICE
When the Food and Drug Administration approved a new type of cholesterol-lowering medicine in 2002, it did so on the basis of a handful of clinical trials covering a total of 3,900 patients. None of the patients took the medicine for more than 12 weeks, and the trials offered no evidence that it had reduced heart attacks or cardiovascular disease, the goal of any cholesterol drug.
